The Pharmacy Times® Women's Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to health conditions that affect women, including gynecological health and maternal health.
April 26th 2024
The approval is based on data from Study 5310, evaluating the pharmacokinetics, safety, and efficacy of Biktarvy (Gilead Sciences Inc) in pregnant individuals.
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Clinical Overview: The Addition of Curcumin to Standard Ovarian Cancer Chemotherapy
For the management of ovarian cancer, it has been observed in both cellular and animal models that curcumin suppresses cell proliferation and promotes apoptosis.
Read More
Lawsuit Challenges States’ Ability to Bar Access to Mifepristone
March 16th 2023Without a constitutional right to abortion, mail order pharmacy providers need to consider both the federal requirements and various state laws in how they approach the dispensing of mifepristone across state lines.
Read More
COVID-19 Vaccination During Pregnancy Found to Protect Infants Against Infection, Hospital Admission
March 3rd 2023The efficacy of 2 doses against Omicron infection was highest when the second vaccine dose was given in the third trimester of pregnancy compared with the first or second trimesters.
Read More